MXCT
Maxcyte·NASDAQ
--
--(--)
--
--(--)
MXCT Filings
Filing Date
Form Description
Form Type
2026-02-05
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-05 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-21
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-21 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-12 · Earnings Call
MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-05
Form 8-K - Current report
Key Events
2025-11-05 · Key Events
Form 8-K - Current report
2025-11-04
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-04 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-03
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-03 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
